𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of 6 microRNAs in prostate cancer and its significance

✍ Scribed by Li, Ming ;Cao, Liyu ;Zhang, Hongfu ;Yin, Yu ;Xu, Xiaochun

Publisher
Springer-Verlag
Year
2009
Weight
521 KB
Volume
6
Category
Article
ISSN
1672-7118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EBAG9/RCAS1 expression and its prognosti
EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer
✍ Satoru Takahashi; Tomohiko Urano; Fujiko Tsuchiya; Tetsuya Fujimura; Tadaichi Ki 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 1 views

## Abstract Estrogen receptor‐binding fragment‐associated gene 9 (EBAG9) has been identified as a primary estrogen‐responsive gene from MCF‐7 human breast cancer cells (Watanabe T, __et al.__, Mol Cell Biol 1998;18:442–9). EBAG9 is identical with RCAS1 (receptor‐binding cancer antigen expressed on

Prognostic significance of β-microsemino
Prognostic significance of β-microseminoprotein mRNA expression in prostate cancer
✍ Hideki Sakai; Toshifumi Tsurusaki; Shigeru Kanda; Takehiko Koji; Jim W. Xuan; Yu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

BACKGROUND. Human ␤-microseminoprotein (␤-MSP or PSP94) is a small protein secreted by prostatic epithelial cells. We recently reported the presence of low levels of ␤-MSP mRNA expression and protein in most prostate cancer tissues. METHODS. ␤-MSP and mRNA expression was examined by in situ hybridiz

The novel tumor-suppressor Mel-18 in pro
The novel tumor-suppressor Mel-18 in prostate cancer: Its functional polymorphism, expression and clinical significance
✍ Wei Wang; Takeshi Yuasa; Norihiko Tsuchiya; Zhiyong Ma; Shinya Maita; Shintaro N 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 339 KB 👁 1 views

## Abstract Mel‐18 is a member of the polycomb group (PcG) proteins, which are chromatin regulatory factors and play important roles in development and oncogenesis. This study was designed to investigate the clinical and prognostic significance of Mel‐18 in patients with prostate cancer. A total of

LRIG1 and the liar paradox in prostate c
LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer
✍ Marcus Thomasson; Baofeng Wang; Peter Hammarsten; Anna Dahlman; Jenny Liao Perss 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 487 KB 👁 1 views

## Abstract The course of prostate cancer varies greatly, and additional prognostic markers are needed. Leucine‐rich repeats and immunoglobulin‐like domains protein 1 (LRIG1) is an endogenous inhibitor of growth factor signaling and a proposed tumor suppressor. Publicly available gene expression da